Who
John R. Stuelpnagel
Director
Company insider
Files Form 4 as: Director, 10x Genomics; Sr VP and COO, Illumina.
In numbers
- Trades disclosed
- 279
- Buys
- 0
- Sells
- 67
- Bought
- $0
- Sold
- $52.9M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 29 Dec 2005
- Last trade
- 3 Sep 2026
- Last filed
- 8 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Sep 2026filed 8 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $425K7,012 at $60.66 | filing |
| 3 Sep 2026filed 8 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $423K6,814 at $62.11 | filing |
| 3 Sep 2026filed 8 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $387K6,174 at $62.61 | filing |
| 3 Sep 2026filed 8 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $425K7,012 at $60.66 | filing |
| 3 Sep 2026filed 8 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $423K6,814 at $62.11 | filing |
| 3 Sep 2026filed 8 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $387K6,174 at $62.61 | filing |
| 11 Aug 2026filed 13 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $979K17,000 at $57.58 | filing |
| 11 Aug 2026filed 13 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $176K3,000 at $58.73 | filing |
| 11 Aug 2026filed 13 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $979K17,000 at $57.58 | filing |
| 11 Aug 2026filed 13 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $176K3,000 at $58.73 | filing |
| 4 Jun 2026filed 8 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,829 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,829 at $0.00 | filing |
| 3 Jun 2025filed 5 Jun 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —15,357 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,649 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | TXG 10x Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,661 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —1,865 at $0.00 | filing |
| 5 Jun 2023filed 7 Jun 2023 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $549K10,000 at $54.89 | filing |
| 15 Jun 2022filed 17 Jun 2022 | TXG 10x Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —5,300 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —2,120 at $0.00 | filing |
| 30 Dec 2021filed 4 Jan 2022 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $485K3,218 at $150.56 | filing |
News
7,724 Shares in 10x Genomics $TXG Bought by QP Wealth Management LLCTXG · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name John R. Stuelpnagel; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.